Magnetic resonance spectroscopic imaging in gliomas: clinical diagnosis and radiotherapy planning
BJR|Open · 2020-11 · 2 (1) · 20190026
DOI: 10.1259/bjro.20190026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BJR|Open, 2020-11. Verfasst von Maria Elena Laino und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
The reprogramming of cellular metabolism is a hallmark of cancer diagnosis and prognosis. Proton magnetic resonance spectroscopic imaging (MRSI) is a non-invasive diagnostic technique for investigating brain metabolism to establish cancer diagnosis and IDH gene mutation diagnosis as well as facilitate pre-operative planning and treatment response monitoring. By allowing tissue metabolism to be quantified, MRSI provides added value to conventional MRI. MRSI can generate metabolite maps from a single volume or multiple volume elements within the whole brain. Metabolites such as NAA, Cho and Cr, as well as their ratios Cho:NAA ratio and Cho:Cr ratio, have been used to provide tumor diagnosis and aid in radiation therapy planning as well as treatment assessment. In addition to these common metabolites, 2-hydroxygluterate (2HG) has also been quantified using MRSI following the recent discovery of IDH mutations in gliomas. This has opened up targeted drug development to inhibit the mutant IDH pathway. This review provides guidance on MRSI in brain gliomas, including its acquisition, analysis methods, and evolving clinical applications.
Autor:innen und Institutionen
- Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.
- Department of Radiology, University of Cagliari, 40 Via Università, 09124 Cagliari, Italy.
- Department of Imaging, A.C.Camargo Cancer Center, São Paulo SP, Brazil.
Förderung
- NCI NIH HHS
Zitieren
APA
Laino, M. E., Young, R., Beal, K., Haque, S., Mazaheri, Y., Corrias, G., Bitencourt, A. G., Karimi, S., & Thakur, S. B. (2020). Magnetic resonance spectroscopic imaging in gliomas: clinical diagnosis and radiotherapy planning. BJR|Open, 2(1), 20190026. https://doi.org/10.1259/bjro.20190026
Vancouver
Laino ME, Young R, Beal K, Haque S, Mazaheri Y, Corrias G, et al. Magnetic resonance spectroscopic imaging in gliomas: clinical diagnosis and radiotherapy planning. BJR|Open. 2020;2(1):20190026. doi:10.1259/bjro.20190026
BibTeX
@article{Laino2020,
author = {Laino, Maria Elena and Young, Robert and Beal, Kathryn and Haque, Sofia and Mazaheri, Yousef and Corrias, Giuseppe and Bitencourt, Almir Gv and Karimi, Sasan and Thakur, Sunitha B},
title = {Magnetic resonance spectroscopic imaging in gliomas: clinical diagnosis and radiotherapy planning},
journal = {BJR|Open},
year = {2020},
volume = {2},
number = {1},
pages = {20190026},
doi = {10.1259/bjro.20190026}
}
EUVIMED